Patent Assignment
Reel/Frame 024302/0506
Security Agreement (Patents)
Recorded: 2010-04-28
Received: 2010-04-28
Pages: 15
Assignor
MDRNA RESEARCH, INC.
Executed: 2010-03-31
Assignee
CEQUENT PHARMACEUTICALS, INC.
ONE KENDALL SQUARE, BUILDING 700, CAMBRIDGE, MA, 02139, UNITED STATES
Covered Properties
(11)
Nucleic Acid Compounds for Inhibiting Wnt Gene Expression and Uses Thereof
Application:
12/529,532 →
Nucleic Acid Compounds for Inhibiting Ras Gene Expression and Uses Thereof
Application:
12/529,302 →
Nucleic Acid Compounds for Inhibiting Myc Gene Expression and Uses Thereof
Application:
12/529,138 →
Nucleic Acid Compounds for Inhibiting BCL2 Gene Expression and Uses Thereof
Application:
12/529,011 →
Nucleic Acid Compounds for Inhibiting HIF1A Gene Expression and Uses Thereof
Application:
12/528,786 →
Nucleic Acid Compounds for Inhibiting Erbb Family Gene Expression and Uses Thereof
Application:
12/528,619 →
Nucleic Acid Compounds for Inhibiting Vegf Family Gene Expression and Uses Thereof
Application:
12/528,508 →
Nucleic Acid Compounds for Inhibiting Vegf Gene Expression and Uses Thereof
Application:
12/039,650 →
Nucleic Acid Compounds for Inhibiting Apob Gene Expression and Uses Thereof
Application:
12/039,668 →
Nucleic Acid Compounds for Inhibiting Akt Gene Expression and Uses Thereof
Application:
12/039,662 →
Nucleic Acid Compounds for Inhibiting Erbb Gene Expression and Uses Thereof
Application:
12/039,658 →